Looking for an Investment Analyst

Bringing new innovations to the market; that is the challenge that we, together with researchers from Utrecht University and UMC Utrecht, face every day at Utrecht Holdings. The goal of our team of 15 expert and enthusiastic employees, is to maximize the impact of academic research on people, society and

Timo Koopmans appointed as new Investment Manager of Utrecht Health Seed Fund

The Utrecht Health Seed Fund is happy to announce the start of its new Investment Manager: Timo Koopmans. Timo holds a PhD in medicinal chemistry from Utrecht University and as a startup founder himself, understands the challenges young companies face. Furthermore he has experience at a management & innovation consultancy

Moveshelf raises €1.7M to accelerate growth and international sales of its Information System for Movement Disorders

Utrecht, The Netherlands Moveshelf is a private digital health company which supplies a novel information system for movement and musculoskeletal disorders. With Moveshelf’s certified Software-as-a-Service, healthcare organizations unlock use of mobility measurements in clinical settings, store data from cameras and wearables in one secure place and allow their medical teams

Cresco Spine closes seed investments to develop innovative dynamic surgical therapy for scoliosis

June 24, 2022 – Utrecht, the Netherlands Cresco Spine, a new player in the spinal arena and a spin-off of the University Medical Center Utrecht (the Netherlands), today announced that it raised seed investments from InSpine and Utrecht Health Seed Fund (UHSF) to continue its development of their unique surgical

TargED Biopharmaceuticals raises EUR 39 Million in Series A financing to bring groundbreaking thrombolytic treatment to patients

Our portfolio company Targed Biopharmaceuticals raised Series A financing of € 39 million to develop improved treatments for thrombotic diseases. The financing was co-led by Andera Partners, Fund+, Hadean Ventures, Inkef Capital and Sunstone Life Science Ventures, and joined by existing investors First, Curie Capital and UHSF.   Congratulations to

Utrecht Health Seed Fund’s first anniversary!

Before we knew, we’re celebrating Utrecht Health Seed Fund’s first anniversary! And what a year it has been. We can’t express how proud we are of our exceptional portfolio companies and the talented entrepreneurs and scientists driving these ventures: – TargED Biopharmaceuticals is developing a next generation clot-busting drug with

SentryX closes €3.2M seed funding round for the development of next generation pain relief therapeutics

We are delighted with the new investment in SentryX, a next generation, innovative pain relief therapy platform, focusing on orthopedic surgical post-procedural pain. Press release: June 9, 2021 – Utrecht, the Netherlands SentryX, a spin-off of the University Medical Center Utrecht (the Netherlands) today announced that it raised €3.2M in seed funding

TargED Biopharmaceuticals appoints Ludo Haazen, M.D. as Chief Medical Officer

TargED Biopharmaceuticals, a biotech spin-off of the University Medical Center Utrecht, today announced the appointment of Ludo Haazen as Chief Medical Officer (CMO). Kristof Vercruysse, CEO of TargED commented: “We are delighted that Ludo is joining our team as CMO. In Ludo, we found the ideal candidate to support the

Nieuws

Looking for an Investment Analyst

Bringing new innovations to the market; that is the challenge…

Timo Koopmans appointed as new Investment Manager of Utrecht Health Seed Fund

The Utrecht Health Seed Fund is happy to announce the start of…

Cresco Spine closes seed investments to develop innovative dynamic surgical therapy for scoliosis

June 24, 2022 - Utrecht, the Netherlands Cresco Spine, a new…

Utrecht Health Seed Fund’s first anniversary!

Before we knew, we’re celebrating Utrecht Health Seed Fund’s…

SentryX closes €3.2M seed funding round for the development of next generation pain relief therapeutics

We are delighted with the new investment in SentryX, a next generation,…

TargED Biopharmaceuticals appoints Ludo Haazen, M.D. as Chief Medical Officer

TargED Biopharmaceuticals, a biotech spin-off of the University…

NTrans Technologies closes Series A investment to accelerate development of gene editing therapy

We're excited to be investing in NTrans Technologies BV, a gene…

Moveshelf closes seed investment to accelerate digital transformation of diagnosis and care for movement disorders

We proudly announce UHSF's second investment, in Moveshelf, together…